{
    "organizations": [],
    "uuid": "2cfb5f73406534897e515a2ace0596a15d24750f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-celcuity-q1-loss-per-share-019/brief-celcuity-q1-loss-per-share-0-19-idUSASC0A219",
    "ord_in_thread": 0,
    "title": "BRIEF-Celcuity Q1 Loss Per Share $0.19",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 14 (Reuters) - Celcuity Inc:\n* CELCUITY REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS * Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.16\n* Q1 LOSS PER SHARE $0.19 * CELCUITY-INTERIM RESULTS OF CLINICAL TRIAL IN COLLABORATION WITH NSABP FOUNDATION, GENENTECH EXPECTED IN Q1 OR Q2 2019, INSTEAD OF 2018 END ANTICIPATED EARLIER Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. 0 : 0 narrow-browser-and-phone medium-browser-and-portrait-tablet landscape-tablet medium-wide-browser wide-browser-and-larger medium-browser-and-landscape-tablet medium-wide-browser-and-larger above-phone portrait-tablet-and-above above-portrait-tablet landscape-tablet-and-above landscape-tablet-and-medium-wide-browser portrait-tablet-and-below landscape-tablet-and-below Apps Newsletters Reuters Plus Advertising Guidelines Cookies Terms of Use Privacy\nAll Quote: s delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.\nÂ© 2018 Reuters. All Rights Reserved.",
    "published": "2018-05-15T04:08:00.000+03:00",
    "crawled": "2018-05-15T13:59:25.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "celcuity",
        "inc",
        "celcuity",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "q1",
        "adjusted",
        "loss",
        "per",
        "share",
        "q1",
        "loss",
        "per",
        "share",
        "result",
        "clinical",
        "trial",
        "collaboration",
        "nsabp",
        "foundation",
        "genentech",
        "expected",
        "q1",
        "q2",
        "instead",
        "end",
        "anticipated",
        "earlier",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle",
        "apps",
        "newsletter",
        "reuters",
        "plus",
        "advertising",
        "guideline",
        "cooky",
        "term",
        "use",
        "privacy",
        "quote",
        "delayed",
        "minimum",
        "minute",
        "see",
        "complete",
        "list",
        "exchange",
        "delay",
        "reuters",
        "right",
        "reserved"
    ]
}